Fluidigm Announces Second Quarter 2021 Financial Results with Total Revenue of $31.0 Million

NEXT STORY
SIGA Reports Financial Results for Three and Six Months Ended June 30, 2021
PREV STORY
Oyster Point Pharma Reports Second Quarter 2021 Financial Results and Recent Business Highlights
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Revelation Biosciences Inc. Receives Approval to Initiate Phase 2b Viral Challenge Study of REVTx 99, an Experimental Prophylactic Treatment for the Prevention of Respiratory Viral Infections

author_avatar
NASDAQ Market News

Global Biologics Safety Testing Market Size to Grow at a CAGR of 12.3% from 2021 to 2030

author_avatar
NASDAQ Market News

Atreca Announces Poster Presentation at the Virtual American Association for Cancer Research (AACR) Annual Meeting

author_avatar
NASDAQ Market News